Lidocaine Cream Sold Online Poses Life-Threatening Risk to Children, Says CPSC

A lidocaine numbing cream marketed by Mad Rabbit has been flagged as a serious hazard to children due to non-compliant packaging, according to a July 17 warning issued by the U.S. Consumer Product Safety Commission (CPSC). The product, called “RELIEVE” Lidocaine Numbing Cream, is being sold without child-resistant packaging, which violates federal safety standards and could result in accidental poisoning or death if ingested by young children.

The CPSC states that the cream contains more than 5 milligrams of lidocaine, a threshold that legally requires child-resistant packaging under the Poison Prevention Packaging Act. Despite the risk and a formal Notice of Violation issued to Mad Rabbit, the Ohio-based company has not initiated a product recall or offered a remedy to consumers. The numbing cream is sold online through the company’s website for about $26 and may also be included in a larger tattoo kit priced at $125.

While no injuries have been publicly reported, the federal agency is urging consumers to immediately remove the product from areas accessible to children and safely dispose of it. Because no recall has been issued, families must take their own steps to ensure safety within their homes.

This warning highlights the ongoing concern surrounding child safety and over-the-counter topical medications. Without compliant packaging, even small amounts of lidocaine can cause severe adverse reactions in children. Residents are reminded that it is illegal to resell products subject to government recall or safety violation, even if the product appears unused or sealed.

Article by multiple contributors, based upon information from the U.S. Consumer Product Safety Commission

Video Spotlight